Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1995 Nov;163(5):454–462.

Neuroendocrine disorders of the gut.

L F Yee 1, S J Mulvihill 1
PMCID: PMC1303170  PMID: 8533409

Abstract

The regulation of gastrointestinal function is known to involve elements of the enteric nervous system. Processes such as secretion, motility, blood flow, and immune function are all influenced by a complex network of neurons whose cell bodies lie in the gut. These neurons use a wide spectrum of substances as neurotransmitters, although the majority use peptides once thought to function only as gut hormones. It has been increasingly recognized that abnormalities of this neuroendocrine regulatory system underlie many gastrointestinal disorders. The most obvious are states of peptide excess found in patients with gut endocrine tumors such as carcinoid, gastrinoma, and somatostatinoma. Conversely, other disorders appear to be related to deficiency states. Examples include both achalasia and Hirschsprung's disease (congenital megacolon), where the loss of inhibitory neural action leads to abnormalities of peristalsis and sphincter function. Evidence for abnormal neuroendocrine regulation leading to disease states is increasing for many other gastrointestinal disorders.

Full text

PDF
454

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggestrup S., Uddman R., Sundler F., Fahrenkrug J., Håkanson R., Sørensen H. R., Hambraeus G. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology. 1983 May;84(5 Pt 1):924–927. [PubMed] [Google Scholar]
  2. Bayliss W. M., Starling E. H. The mechanism of pancreatic secretion. J Physiol. 1902 Sep 12;28(5):325–353. doi: 10.1113/jphysiol.1902.sp000920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bealer J. F., Natuzzi E. S., Buscher C., Ursell P. C., Flake A. W., Adzick N. S., Harrison M. R. Nitric oxide synthase is deficient in the aganglionic colon of patients with Hirschsprung's disease. Pediatrics. 1994 Apr;93(4):647–651. [PubMed] [Google Scholar]
  4. Blalock J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 1989 Jan;69(1):1–32. doi: 10.1152/physrev.1989.69.1.1. [DOI] [PubMed] [Google Scholar]
  5. Camilleri M., Malagelada J. R., Abell T. L., Brown M. L., Hench V., Zinsmeister A. R. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989 Mar;96(3):704–712. [PubMed] [Google Scholar]
  6. Cheng C. A., Geoghegan J. G., Lawson D. C., Berlangieri S. U., Akwari O., Pappas T. N. Central and peripheral effects of CCK receptor antagonists on satiety in dogs. Am J Physiol. 1993 Aug;265(2 Pt 1):G219–G223. doi: 10.1152/ajpgi.1993.265.2.G219. [DOI] [PubMed] [Google Scholar]
  7. Dodds W. J., Dent J., Hogan W. J., Patel G. K., Toouli J., Arndorfer R. C. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology. 1981 Feb;80(2):327–333. [PubMed] [Google Scholar]
  8. Dodge J. A. Production of duodenal ulcers and hypertrophic pyloric stenosis by administration of pentagastrin to pregnant and newborn dogs. Nature. 1970 Jan 17;225(5229):284–285. doi: 10.1038/225284a0. [DOI] [PubMed] [Google Scholar]
  9. Grider J. R., Makhlouf G. M. Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation. Am J Physiol. 1986 Jul;251(1 Pt 1):G40–G45. doi: 10.1152/ajpgi.1986.251.1.G40. [DOI] [PubMed] [Google Scholar]
  10. Gross V., Andus T., Caesar I., Roth M., Schölmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology. 1992 Feb;102(2):514–519. doi: 10.1016/0016-5085(92)90098-j. [DOI] [PubMed] [Google Scholar]
  11. Guelrud M., Rossiter A., Souney P. F., Rossiter G., Fanikos J., Mujica V. The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia. Gastroenterology. 1992 Aug;103(2):377–382. doi: 10.1016/0016-5085(92)90824-i. [DOI] [PubMed] [Google Scholar]
  12. Harvey R. F., Read A. E. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet. 1973 Jan 6;1(7793):1–3. doi: 10.1016/s0140-6736(73)91219-1. [DOI] [PubMed] [Google Scholar]
  13. Huang P. L., Dawson T. M., Bredt D. S., Snyder S. H., Fishman M. C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993 Dec 31;75(7):1273–1286. doi: 10.1016/0092-8674(93)90615-w. [DOI] [PubMed] [Google Scholar]
  14. Koch T. R., Carney J. A., Go L., Go V. L. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology. 1988 Feb;94(2):300–310. doi: 10.1016/0016-5085(88)90416-7. [DOI] [PubMed] [Google Scholar]
  15. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990 Nov 1;323(18):1246–1249. doi: 10.1056/NEJM199011013231805. [DOI] [PubMed] [Google Scholar]
  16. Larsson L. T., Sundler F. Neuronal markers in Hirschsprung's disease with special reference to neuropeptides. Acta Histochem Suppl. 1990;38:115–125. [PubMed] [Google Scholar]
  17. Lincoln J., Crowe R., Kamm M. A., Burnstock G., Lennard-Jones J. E. Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology. 1990 May;98(5 Pt 1):1219–1225. doi: 10.1016/0016-5085(90)90336-y. [DOI] [PubMed] [Google Scholar]
  18. Lu Y. X., Wiley J., Chung O. Mechanisms regulating somatostatin release and somatostatin-induced acetylcholine release from the myenteric plexus. Metabolism. 1990 Sep;39(9 Suppl 2):131–133. doi: 10.1016/0026-0495(90)90230-a. [DOI] [PubMed] [Google Scholar]
  19. Mantyh C. R., Gates T. S., Zimmerman R. P., Welton M. L., Passaro E. P., Jr, Vigna S. R., Maggio J. E., Kruger L., Mantyh P. W. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A. 1988 May;85(9):3235–3239. doi: 10.1073/pnas.85.9.3235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mearin F., Mourelle M., Guarner F., Salas A., Riveros-Moreno V., Moncada S., Malagelada J. R. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993 Nov;23(11):724–728. doi: 10.1111/j.1365-2362.1993.tb01292.x. [DOI] [PubMed] [Google Scholar]
  21. O'Dorisio T. M., Mekhjian H. S., Gaginella T. S. Medical therapy of VIPomas. Endocrinol Metab Clin North Am. 1989 Jun;18(2):545–556. [PubMed] [Google Scholar]
  22. O'Morain C., Bishop A. E., McGregor G. P., Levi A. J., Bloom S. R., Polak J. M., Peters T. J. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut. 1984 Jan;25(1):57–61. doi: 10.1136/gut.25.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pearse A. G. 5-hydroxytryptophan uptake by dog thyroid 'C' cells, and its possible significance in polypeptide hormone production. Nature. 1966 Aug 6;211(5049):598–600. doi: 10.1038/211598a0. [DOI] [PubMed] [Google Scholar]
  24. Pullman W. E., Elsbury S., Kobayashi M., Hapel A. J., Doe W. F. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology. 1992 Feb;102(2):529–537. doi: 10.1016/0016-5085(92)90100-d. [DOI] [PubMed] [Google Scholar]
  25. Rees W. D., Leigh R. J., Christofides N. D., Bloom S. R., Turnberg L. A. Interdigestive motor activity in patients with systemic sclerosis. Gastroenterology. 1982 Sep;83(3):575–580. [PubMed] [Google Scholar]
  26. Reynolds J. C., Ouyang A., Lee C. A., Baker L., Sunshine A. G., Cohen S. Chronic severe constipation. Prospective motility studies in 25 consecutive patients. Gastroenterology. 1987 Feb;92(2):414–420. [PubMed] [Google Scholar]
  27. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 Feb;14(2):125–132. doi: 10.1136/gut.14.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rolny P., Arlebäck A., Funch-Jensen P., Kruse A., Ravnsbaeck J., Järnerot G. Paradoxical response of sphincter of Oddi to intravenous injection of cholecystokinin or ceruletide. Manometric findings and results of treatment in biliary dyskinesia. Gut. 1986 Dec;27(12):1507–1511. doi: 10.1136/gut.27.12.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Saffouri B., Weir G. C., Bitar K. N., Makhlouf G. M. Gastrin and somatostatin secretion by perfused rat stomach: functional linkage of antral peptides. Am J Physiol. 1980 Jun;238(6):G495–G501. doi: 10.1152/ajpgi.1980.238.6.G495. [DOI] [PubMed] [Google Scholar]
  30. Schubert M. L., Edwards N. F., Arimura A., Makhlouf G. M. Paracrine regulation of gastric acid secretion by fundic somatostatin. Am J Physiol. 1987 Apr;252(4 Pt 1):G485–G490. doi: 10.1152/ajpgi.1987.252.4.G485. [DOI] [PubMed] [Google Scholar]
  31. Schuffler M. D., Lowe M. C., Bill A. H. Studies of idiopathic intestinal pseudoobstruction. I. Hereditary hollow visceral myopathy: clinical and pathological studies. Gastroenterology. 1977 Aug;73(2):327–338. [PubMed] [Google Scholar]
  32. Shuttleworth C. W., Murphy R., Furness J. B. Evidence that nitric oxide participates in non-adrenergic inhibitory transmission to intestinal muscle in the guinea-pig. Neurosci Lett. 1991 Sep 2;130(1):77–80. doi: 10.1016/0304-3940(91)90231-h. [DOI] [PubMed] [Google Scholar]
  33. Snyder S. H. Nitric oxide: first in a new class of neurotransmitters. Science. 1992 Jul 24;257(5069):494–496. doi: 10.1126/science.1353273. [DOI] [PubMed] [Google Scholar]
  34. Soudah H. C., Hasler W. L., Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991 Nov 21;325(21):1461–1467. doi: 10.1056/NEJM199111213252102. [DOI] [PubMed] [Google Scholar]
  35. Telander R. L., Morgan K. G., Kreulen D. L., Schmalz P. F., Kelly K. A., Szurszewski J. H. Human gastric atony with tachygastria and gastric retention. Gastroenterology. 1978 Sep;75(3):497–501. [PubMed] [Google Scholar]
  36. Tsuto T., Okamura H., Fukui K., Obata H. L., Terubayashi H., Iwai N., Majima S., Yanaihara N., Ibata Y. An immunohistochemical investigation of vasoactive intestinal polypeptide in the colon of patients with Hirschsprung's disease. Neurosci Lett. 1982 Dec 23;34(1):57–62. doi: 10.1016/0304-3940(82)90092-1. [DOI] [PubMed] [Google Scholar]
  37. VERNER J. V., MORRISON A. B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958 Sep;25(3):374–380. doi: 10.1016/0002-9343(58)90075-5. [DOI] [PubMed] [Google Scholar]
  38. Vanderwinden J. M., De Laet M. H., Schiffmann S. N., Mailleux P., Lowenstein C. J., Snyder S. H., Vanderhaeghen J. J. Nitric oxide synthase distribution in the enteric nervous system of Hirschsprung's disease. Gastroenterology. 1993 Oct;105(4):969–973. doi: 10.1016/0016-5085(93)90938-9. [DOI] [PubMed] [Google Scholar]
  39. Vanderwinden J. M., Mailleux P., Schiffmann S. N., Vanderhaeghen J. J., De Laet M. H. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med. 1992 Aug 20;327(8):511–515. doi: 10.1056/NEJM199208203270802. [DOI] [PubMed] [Google Scholar]
  40. Virgolini I., Raderer M., Kurtaran A., Angelberger P., Banyai S., Yang Q., Li S., Banyai M., Pidlich J., Niederle B. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med. 1994 Oct 27;331(17):1116–1121. doi: 10.1056/NEJM199410273311703. [DOI] [PubMed] [Google Scholar]
  41. Wright N. A., Poulsom R., Stamp G., Van Noorden S., Sarraf C., Elia G., Ahnen D., Jeffery R., Longcroft J., Pike C. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 1993 Jan;104(1):12–20. doi: 10.1016/0016-5085(93)90830-6. [DOI] [PubMed] [Google Scholar]
  42. ZOLLINGER R. M., ELLISON E. H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8. [PMC free article] [PubMed] [Google Scholar]
  43. von der Ohe M. R., Camilleri M., Kvols L. K., Thomforde G. M. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993 Oct 7;329(15):1073–1078. doi: 10.1056/NEJM199310073291503. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES